- Home
- ADCT vs CIA Comparison
ADCT vs CIA Comparison
Compare ADCT & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- CIA
- Stock Information
- Founded
- ADCT 2011
- CIA 1969
- Country
- ADCT Switzerland
- CIA United States
- Employees
- ADCT N/A
- CIA N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- ADCT Health Care
- CIA Finance
- Exchange
- ADCT Nasdaq
- CIA Nasdaq
- Market Cap
- ADCT 224.3M
- CIA 230.6M
- IPO Year
- ADCT 2020
- CIA N/A
- Fundamental
- Price
- ADCT $1.72
- CIA $4.59
- Analyst Decision
- ADCT Strong Buy
- CIA
- Analyst Count
- ADCT 5
- CIA 0
- Target Price
- ADCT $8.00
- CIA N/A
- AVG Volume (30 Days)
- ADCT 709.5K
- CIA 100.3K
- Earning Date
- ADCT 03-12-2025
- CIA 03-13-2025
- Dividend Yield
- ADCT N/A
- CIA N/A
- EPS Growth
- ADCT N/A
- CIA N/A
- EPS
- ADCT N/A
- CIA 0.43
- Revenue
- ADCT $70,717,000.00
- CIA $248,376,000.00
- Revenue This Year
- ADCT $6.81
- CIA N/A
- Revenue Next Year
- ADCT $11.23
- CIA $3.85
- P/E Ratio
- ADCT N/A
- CIA $10.87
- Revenue Growth
- ADCT N/A
- CIA 3.02
- 52 Week Low
- ADCT $1.68
- CIA $1.78
- 52 Week High
- ADCT $6.04
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- ADCT 40.45
- CIA 59.40
- Support Level
- ADCT $1.68
- CIA $4.05
- Resistance Level
- ADCT $1.87
- CIA $4.75
- Average True Range (ATR)
- ADCT 0.13
- CIA 0.21
- MACD
- ADCT 0.00
- CIA 0.06
- Stochastic Oscillator
- ADCT 8.65
- CIA 70.97
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.